Transient Ischemic Attack
📧 Sign up to get email alerts when something new happens for Transient Ischemic Attack.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-26Clinical Trial Update: Immunomodulatory Effects of PCSK9 Inhibition
A clinical trial examining the immunomodulatory effects of PCSK9 inhibition for cardiovascular disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-05-27Clinical Trial Update: The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack [Phase 4]
A Phase 4 clinical trial evaluating dual antiplatelet therapy in acute transient ischemic attack and minor stroke has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-05Clinical Trial Update: E-Selectin Nasal Instillation to Prevent Secondary Stroke [Phase 1]
Phase 1 trial evaluating an E-Selectin nasal instillation to prevent secondary stroke was withdrawn before completion.
-
CLINICAL_TRIALS withdrawal · 2015-02-04Clinical Trial Update: Study of Admission Versus Discharge After Transient Ischemic Attack (TIA) [Phase 1]
A Phase 1 clinical trial comparing admission versus discharge after a transient ischemic attack was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-08-20Clinical Trial Update: China Stroke Secondary Prevention Trial [NA]
The China Stroke Secondary Prevention Trial has been withdrawn from ClinicalTrials.gov.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2009-04-23EMA Application withdrawn: Clopidogrel Teva Pharma (clopidogrel) — Teva Pharma B.V.
The EMA application for Clopidogrel Teva Pharma (clopidogrel) has been withdrawn.